Importer of Controlled Substances Application: Anderson Brecon, Inc., 37525-37526 [2018-16464]
Download as PDF
<![CDATA[
37525
Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices
Controlled substance
Phenylacetone ................
Poppy Straw Concentrate.
Tapentadol ......................
Drug
code
Schedule
8501
9670
II
II
9780
II
The company plans to import narcotic
raw materials to manufacture bulk
controlled substances for distribution to
its customers. The company plans to
import an intermediate form of
tapentadol (9780), to bulk manufacture
tapentadol for distribution to its
customers.
Dated: July 23, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–16467 Filed 7–31–18; 8:45 am]
BILLING CODE 4410–09–P
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
delegated to the Assistant Administrator
of the DEA Diversion Control Division
(‘‘Assistant Administrator’’) pursuant to
section 7 of 28 CFR part 0, appendix to
subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on July 3,
2018, Galephar Pharmaceutical
Research Inc., #100 Carr 198 Industrial
Park, Juncos, Puerto Rico 00777 applied
to be registered as an importer of the
following basic class of controlled
substance:
Drug
code
Controlled substance
DEPARTMENT OF JUSTICE
Hydromorphone ..............
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Galephar Pharmaceutical
Research Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 31, 2018. Such persons
may also file a written request for a
hearing on the application on or before
August 31, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
sradovich on DSK3GMQ082PROD with NOTICES
DATES:
VerDate Sep<11>2014
20:07 Jul 31, 2018
Jkt 244001
Schedule
9150
II
The company plans to import the
listed controlled substance in finished
dosage form for clinical trials, research
and analytical purposes.
Dated: July 23, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–16466 Filed 7–31–18; 8:45 am]
BILLING CODE 4410–09–P
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Ultra Scientific Inc.
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 31, 2018. Such persons
may also file a written request for a
hearing on the application on or before
August 31, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
DATES:
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Controlled substance
Marihuana .......................
Tetrahydrocannabinols ...
DEPARTMENT OF JUSTICE
ACTION:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on April
4, 2018, Ultra Scientific Inc., 250 Smith
Street, North Kingstown, Rhode Island
02852 applied to be registered as an
importer of the following basic classes
of controlled substances:
Drug
code
Schedule
7360
7370
I
I
The company plans to import
derivatives of the listed controlled
substances for use as chemical
standards for testing and calibration
only of analytical equipment. The above
controlled substances will not be
imported for human or animal
consumption.
Dated: July 23, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–16465 Filed 7–31–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Anderson Brecon, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
DATES:
E:\FR\FM\01AUN1.SGM
01AUN1
37526
Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices
issuance of the proposed registration on
or before August 31, 2018. Such persons
may also file a written request for a
hearing on the application on or before
August 31, 2018.
DEPARTMENT OF JUSTICE
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; New
Collection
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
February 6, 2018, Anderson Brecon,
Inc., 4545 Assembly Drive, Rockford,
Illinois 61109 applied to be registered as
an importer of Tetrahydrocannabinols
(7370), a basic class of controlled
substance listed in Schedule I.
The company plans to import for
clinical trial only. Approval of
applications will occur only when
registrant’s business activity is
consistent with what is authorized
under 21 U.S.C 952 (a) (2).
Authorization will not extend to the
import of FDA approved or nonapproved finished dosage forms for
commercial sale.
sradovich on DSK3GMQ082PROD with NOTICES
SUPPLEMENTARY INFORMATION:
Dated: July 20, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–16464 Filed 7–31–18; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
20:07 Jul 31, 2018
Jkt 244001
Office of Justice Programs
[OMB Number XXXX-New]
SMART Office, Office of Justice
Programs, Department of Justice.
ACTION: 30 Day Notice.
AGENCY:
The Department of Justice,
Office of Justice Programs, SMART
Office, is submitting the following
information collection request to the
Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
DATES: The Department of Justice
encourages public comment and will
accept input until August 31, 2018.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Samantha Opong, Program Specialist,
SMART Office, 810 7th Street NW
Washington, DC 20531,
Samantha.Opong@usdoj.gov, (202) 514–
9320. Written comments and/or
suggestions can also be sent to the
Office of Management and Budget,
Office of Information and Regulatory
Affairs, Attention Department of Justice
Desk Officer, Washington, DC 20503 or
sent to OIRA_submissions@
omb.eop.gov.
SUMMARY:
Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the SMART Office,
including whether the information
will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
This is a ‘‘New collection,’’ the
collection has not previously been used
or sponsored by the SMART Office.
The Title of the Form/Collection:
Campus Information Sharing and
Response Project.
As part of a fellowship project in the
Office of Sex Offender Sentencing,
Monitoring, Apprehending, Registering,
and Tracking (SMART), Office of Justice
Programs at the U.S. Department of
Justice, the Campus Information Sharing
and Response project is exploring how
institutions of higher education share,
respond and coordinate information to
prevent sexual assault perpetration.
This project will collect through an
online questionnaire information about
current practices utilized by colleges
and universities with regards to the
following:
• Policies and practices regarding
registered sex offenders who may be
students or employees
• Policies and practices regarding
individuals found responsible and
sanctioned for campus sexual
misconduct policy violations
• Policies and practices used in
reviewing criminal or disciplinary
sexual misconduct history of
prospective or current students.
2. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
There is no agency form number for this
collection. The applicable component
within the Department of Justice is the
SMART Office.
Affected public who will be asked or
required to respond, as well as a brief
abstract: The respondents to this
collection/affected public includes
business or other for profit institutions
of higher education, and not-for-profit
institutions. The SMART Office is
exploring how institutions of higher
education share, respond and
coordinate information to prevent
sexual assault perpetration. This project
will collect information about current
policies and practices utilized by
colleges and universities regarding
registered sex offenders who may be
students or employees; individuals
E:\FR\FM\01AUN1.SGM
01AUN1
]]>Agencies
[Federal Register Volume 83, Number 148 (Wednesday, August 1, 2018)]
[Notices]
[Pages 37525-37526]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16464]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Anderson Brecon,
Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
[[Page 37526]]
issuance of the proposed registration on or before August 31, 2018.
Such persons may also file a written request for a hearing on the
application on or before August 31, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on
February 6, 2018, Anderson Brecon, Inc., 4545 Assembly Drive, Rockford,
Illinois 61109 applied to be registered as an importer of
Tetrahydrocannabinols (7370), a basic class of controlled substance
listed in Schedule I.
The company plans to import for clinical trial only. Approval of
applications will occur only when registrant's business activity is
consistent with what is authorized under 21 U.S.C 952 (a) (2).
Authorization will not extend to the import of FDA approved or non-
approved finished dosage forms for commercial sale.
Dated: July 20, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-16464 Filed 7-31-18; 8:45 am]
BILLING CODE 4410-09-P
